Valuation: Molecure S.A.

Market Cap 120M 31.98M 27.96M 25.69M 23.95M 45.42M 3.05B 46.11M 308M 1.5B 120M 117M 5.16B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 89.01M 23.74M 20.75M 19.07M 17.78M 33.72M 2.26B 34.23M 229M 1.11B 89.11M 87.2M 3.83B EV / Sales 2025
20.9x
EV / Sales 2026 * 9.45x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+3.78%
1 week+8.05%
Current month+9.82%
1 month+5.41%
3 months+14.61%
6 months-13.09%
Current year-8.48%
1 week 5.38
Extreme 5.38
6.1
1 month 5.25
Extreme 5.25
6.2
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.06
3 years 4.98
Extreme 4.98
25.5
5 years 4.98
Extreme 4.98
51
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 03/01/2023
Director TitleAgeSince
Director/Board Member - 30/06/2021
Chairman 38 01/06/2023
Director/Board Member - 14/01/2022
Date Insider Type Main position Quantity % Market Cap.
22/12/23Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%+8.05%+1.00%-70.82% 32.03M
+0.68%+5.92%+80.45%+137.78% 58.73B
+2.32%+5.89%+76.81%+99.20% 53.92B
-10.61%+8.38%-9.90%-9.62% 24.67B
-0.30%+6.82%+13.60%+428.91% 24.19B
+4.74%+13.47%+46.43%+0.03% 18.8B
-0.29%+9.78%+44.62%-27.94% 17.61B
0.00%+16.74%+171.12%+355.99% 16.25B
+3.50%+4.92%+26.07%+192.26% 14.04B
+6.72%+20.94%+51.67% - 13.9B
Average +2.96%+7.26%+50.19%+122.86% 24.21B
Weighted average by Cap. +2.44%+5.53%+59.78%+138.32%

Financials

2025 2026 *
Net sales 3.9M 1.04M 909K 836K 779K 1.48M 99.04M 1.5M 10.03M 48.68M 3.9M 3.82M 168M 13.1M 3.49M 3.05M 2.81M 2.62M 4.96M 333M 5.04M 33.7M 164M 13.11M 12.83M 563M
Net income -21.2M -5.65M -4.94M -4.54M -4.23M -8.03M -538M -8.15M -54.53M -265M -21.22M -20.77M -912M -71.6M -19.1M -16.69M -15.34M -14.3M -27.12M -1.82B -27.54M -184M -894M -71.68M -70.14M -3.08B
Net Debt -30.9M -8.24M -7.2M -6.62M -6.17M -11.71M -785M -11.88M -79.49M -386M -30.93M -30.27M -1.33B 3.9M 1.04M 909K 836K 779K 1.48M 99.04M 1.5M 10.03M 48.68M 3.9M 3.82M 168M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
03/07/26 PLN 6.040 +3.78% 211,240
02/07/26 PLN 5.820 +6.01% 70,840
01/07/26 PLN 5.490 -0.18% 15,744
30/06/26 PLN 5.500 +1.10% 5,812
29/06/26 PLN 5.440 -2.68% 7,309
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.820PLN
Average target price
12.45PLN
Spread / Average Target
+113.92%

Quarterly revenue - Rate of surprise